Company Quest Laboratories Limited

QUESTLAB

INE0TNW01017

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:09 2026-10-06 am EDT			5-day change	1st Jan Change
92.60 ^INR	-3.54%		+4.04%	-15.89%

Sep. 13	Quest Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
Feb. 12	Quest Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Business description: Quest Laboratories Limited

Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.

Number of employees: 99

Sales by Activity: Quest Laboratories Limited

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Drugs And Chemicals	595M	616M	826M	1.04B	1.12B

See all business segments

Geographical breakdown of sales: Quest Laboratories Limited

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
India	595M	616M	826M	1.04B	1.12B

See all geographic segments

Executive Committee: Quest Laboratories Limited

Manager	Title	Age	Since
Anil Kumar Sabarwal CEO	Chief Executive Officer	59	2023-12-31
Ramkrishna Sharma DFI	Director of Finance/CFO	38	2023-12-31
Ayushi Taunk CMP	Compliance Officer	-	2025-09-02
Gopal Krishan PRN	Corporate Officer/Principal	54	2015-06-30

See QUEST LABORATORIES LIMITED governance

Composition of the Board of Directors: Quest Laboratories Limited

Director	Title	Age	Since
Anil Kumar Sabarwal CHM	Chairman	59	2023-12-31
Tejaswini Sabarwal BRD	Director/Board Member	31	2021-03-04
Gautam Chand Kothari BRD	Director/Board Member	73	2024-01-09
Amit Ramesh Chandak BRD	Director/Board Member	42	2024-01-09
Basant Lal Menghwani BRD	Director/Board Member	71	2024-01-09
Umendra Suthar BRD	Director/Board Member	-	2024-06-30
Vinayak Sabarwal BRD	Director/Board Member	-	2024-06-30

Composition of the Board of Directors

Company details: Quest Laboratories Limited

Quest Laboratories Pvt Ltd.

Plot No. 45

454775, Dhar

+91 72 9229 2374

http://www.questlabltd.com

address Quest Laboratories Limited(QUESTLAB)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
QUEST LABORATORIES LIMITED	-3.54%	+4.04%	+2.83%	-	16.33M
ELI LILLY AND COMPANY	+0.02%	-3.52%	+36.11%	+111.11%	1,019B
JOHNSON & JOHNSON	-1.21%	-6.99%	+34.08%	+60.96%	610B
ABBVIE INC.	+1.12%	-0.20%	+13.62%	+80.24%	470B
MERCK & CO., INC.	-3.30%	-6.15%	+56.45%	+34.69%	344B
ROCHE HOLDING AG	+1.16%	+0.94%	+22.26%	+42.12%	336B
NOVARTIS AG	+0.85%	-2.80%	+11.10%	+32.99%	266B
ASTRAZENECA PLC	+2.26%	-3.36%	-5.63%	+9.76%	241B
AMGEN INC.	-0.01%	-3.62%	+35.28%	+52.02%	218B
GILEAD SCIENCES, INC.	-0.08%	-4.98%	+28.34%	+93.61%	179B
Average	+0.29%	-2.07%	+23.44%	+57.50%	368.28B
Weighted average by Cap.	+0.75%	-3.51%	+28.57%	+68.81%